{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:25:36Z","timestamp":1770517536802,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.forsciint.2021.110721","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T03:10:28Z","timestamp":1612926628000},"page":"110721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Alpha-Pyrrolidinopentiothiophenone (\u03b1-PVT): A forensic case study including plasma concentrations"],"prefix":"10.1016","volume":"321","author":[{"given":"Liane D.","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Welter-Luedeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Penzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zangl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Graw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2021.110721_bib1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, High-risk drug use and new psychoactive substances, EMCDDA Rapid Communication, Publications Office of the European Union, Luxembourg, 2017."},{"key":"10.1016\/j.forsciint.2021.110721_bib2","unstructured":"UNOCD, Early warning advisory on new psychoactive substances, https:\/\/www.unodc.org\/LSS\/Home\/NPS, 2020."},{"key":"10.1016\/j.forsciint.2021.110721_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/15563650.2017.1370097","article-title":"Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats","volume":"56","author":"Beck","year":"2018","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.forsciint.2017.12.003","article-title":"MDPV in forensic routine cases: psychotic and aggressive behavior in relation to plasma concentrations","volume":"283","author":"Diestelmann","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.110721_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3460849","article-title":"Flakka-induced prolonged psychosis","volume":"2016","author":"Crespi","year":"2016","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.forsciint.2021.110721_bib6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/dta.2151","article-title":"Alpha-PVP as an active component of herbal highs in Poland between 2013 and 2015","volume":"9","author":"Byrska","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2021.110721_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11419-013-0182-9","volume":"31","author":"Uchiyama","year":"2013","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release","volume":"360","author":"Eshleman","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.forsciint.2021.110721_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00213-017-4562-4","article-title":"Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats","volume":"234","author":"Gatch","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.forsciint.2021.110721_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuint.2018.12.005","article-title":"A novel synthetic cathinone, alpha-pyrrolidinopentiothiophenone (PVT), produces locomotor sensitization in rat: implications for GSK3beta connections in the nucleus accumbens core","volume":"124","author":"Yoon","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.forsciint.2021.110721_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00213-017-4526-8","article-title":"Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents","volume":"234","author":"Cheong","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.forsciint.2021.110721_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/0269881120914213","article-title":"Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats","volume":"34","author":"Gatch","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2021.110721_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12640-016-9640-6","article-title":"Cytotoxic activity of pyrovalerone derivatives, an emerging group of psychostimulant designer cathinones","volume":"30","author":"Wojcieszak","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.forsciint.2021.110721_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/wfs2.1174","article-title":"Relevance of published blood concentrations of new psychoactive substance for rational case interpretation","volume":"1","author":"Welter-Luedeke","year":"2019","journal-title":"WIREs Forensic Sci."},{"key":"10.1016\/j.forsciint.2021.110721_bib15","series-title":"UV-Spectra of Toxic Compounds. Database of Photo-diode Array UV Spectra of Illegal and Therapeutic Drugs, Pesticides, Ecotoxic Substances and Other Poisons","author":"Pragst","year":"2001"},{"key":"10.1016\/j.forsciint.2021.110721_bib16","first-page":"185","article-title":"Richtlinie der Gesellschaft f\u00fcr toxikologische und forensische Chemie, Anhang B; Anforderung an die Validierung von Analysenmethoden","volume":"76","author":"Peters","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"10.1016\/j.forsciint.2021.110721_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4155\/bio.15.237","article-title":"In vitro, in vivo and in silico metabolic profiling of alpha-pyrrolidinopentiothiophenone, a novel thiophene stimulant","volume":"8","author":"Swortwood","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.forsciint.2021.110721_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chroma.2015.04.002","article-title":"Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching","volume":"1397","author":"Concheiro","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2021.110721_bib19","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (alpha-pyrrolidinovalerophenone, alpha-PVP) in the framework of the Council Decision on new psychoactive substances, Publications Office of the European Union, Luxembourg, 2016."},{"key":"10.1016\/j.forsciint.2021.110721_bib20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/15563650.2016.1190979","article-title":"Toxicity evaluation of alpha-pyrrolidinovalerophenone (alpha-PVP): results from intoxication cases within the STRIDA project","volume":"54","author":"Beck","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/15563650.2015.1033630","article-title":"Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine","volume":"53","author":"Helander","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","article-title":"Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project","volume":"53","author":"Beck","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa192","article-title":"A recent human immunodeficiency virus outbreak among people who inject drugs in Munich, Germany, is associated with consumption of synthetic cathinones","volume":"7","author":"Hanke","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.forsciint.2021.110721_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","article-title":"Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention","volume":"69","author":"Glennon","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.forsciint.2021.110721_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13181-014-0446-8","article-title":"Acute methylenedioxypyrovalerone toxicity","volume":"11","author":"Froberg","year":"2015","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jat\/bkt025","article-title":"Analysis of MDPV in blood--determination and interpretation","volume":"37","author":"Adamowicz","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amjmed.2012.02.019","article-title":"Psychoactive \u201cbath salts\u201d intoxication with methylenedioxypyrovalerone","volume":"125","author":"Ross","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.forsciint.2021.110721_bib29","unstructured":"European Monitoring Center for Drugs and Drug Addiction, EMCDDA-Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone), Publications Office of the European Union, Luxembourg, 2014."},{"key":"10.1016\/j.forsciint.2021.110721_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FTD.0b013e318208b693","article-title":"Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry","volume":"33","author":"Ojanpera","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2021.110721_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2017.01.021","article-title":"Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): detection, quantification and studies on human metabolism by GC-MS","volume":"273","author":"Grapp","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.110721_bib32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/dta.2355","article-title":"Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse","volume":"10","author":"Manier","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2021.110721_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11419-013-0183-8","article-title":"SPME-GC-MS analysis of alpha-pyrrolidinovaleorophenone in blood in a fatal poisoning case","volume":"31","author":"Saito","year":"2013","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11419-013-0212-7","article-title":"MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood","volume":"32","author":"Minakata","year":"2014","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2021.110721_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/7854_2016_53","article-title":"Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs","volume":"32","author":"Baumann","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073821000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073821000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:04:47Z","timestamp":1759946687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073821000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":35,"alternative-id":["S0379073821000414"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.110721","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-Pyrrolidinopentiothiophenone (\u03b1-PVT): A forensic case study including plasma concentrations","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.110721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110721"}}